The International Workshop on Cell Therapy for Blood Diseases, hosted by the Department of International Cooperation of the Ministry of Science and Technology of China, and organized by the Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College (IHCAMS), was successfully held in Tianjin from August 15 to 29, 2025.

The workshop recruited 20 physicians and researchers engaged in clinical practice and scientific research on hematologic diseases from Thailand, Belarus, Vietnam, Bangladesh, Indonesia, and Egypt, offering them a two-week high-level, systematic, and professional training.

The program comprehensively covered both fundamental and cutting-edge areas of cell therapy, fully demonstrating China's innovation capacity across the entire chain from basic research and technology development to clinical translation and industrial application. Its aim was to promote the international dissemination and application of China's advanced therapeutic technologies, while deepening scientific and technological cooperation with Belt and Road countries in the health sector.

The curriculum combined theoretical lectures with practical training, and integrated scientific research with clinical translation. Speakers were invited from the University of Pennsylvania, Peking University, Chinese Academy of Sciences, East China Normal University, Tianjin University, along with leading experts, young scholars, and technical leaders from the institute and innovative enterprises. Course topics covered stem cell biology, hematopoietic stem cell transplantation, gene therapy, CAR-T immunotherapy, CAR-T manufacturing processes, single-cell and spatial omics technologies, synthetic biology and biopharmaceutical innovation, as well as the application of artificial intelligence in cell therapy.

In terms of training format, in addition to multiple lectures, participants also engaged in practical teaching and site visits. They visited various clinical centers of the institute, the Haihe Laboratory on Cell Ecosystem, and enterprises including Union Precision, Vcanbio, BGI, and Juventas. Through these activities, trainees gained a comprehensive understanding of the entire technological chain of cell therapy—from R&D, manufacturing, and quality control to clinical application—enhancing both their practical skills and awareness of real-world application scenarios.

The program achieved significant results in international exchange and cooperation. During the training, IHCAMS engaged in in-depth discussions with delegations from Thailand, Bangladesh, and others on future cooperation in clinical services, personnel exchange, and research, reaching preliminary agreements.